BioAtla, Inc. (BCAB)
NASDAQ: BCAB · Real-Time Price · USD
4.310
-0.150 (-3.36%)
At close: Apr 13, 2026, 4:00 PM EDT
4.390
+0.080 (1.86%)
After-hours: Apr 13, 2026, 5:46 PM EDT
BioAtla Employees
BioAtla had 41 employees as of December 31, 2025. The number of employees decreased by 20 or -32.79% compared to the previous year.
Employees
41
Change (1Y)
-20
Growth (1Y)
-32.79%
Revenue / Employee
$48,780
Profits / Employee
-$1,453,829
Market Cap
7.14M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 41 | -20 | -32.79% |
| Dec 31, 2024 | 61 | -4 | -6.15% |
| Dec 31, 2023 | 65 | -1 | -1.52% |
| Dec 31, 2022 | 66 | 10 | 17.86% |
| Dec 31, 2021 | 56 | 20 | 55.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Quince Therapeutics | 36 |
| Processa Pharmaceuticals | 12 |
| MetaVia | 8 |
| TransCode Therapeutics | 7 |
| Acurx Pharmaceuticals | 4 |
| Creative Medical Technology Holdings | 4 |
| Silo Pharma | 3 |
| PharmaCyte Biotech | 2 |
BCAB News
- 13 days ago - BioAtla Announces Share Consolidation - GlobeNewsWire
- 13 days ago - BioAtla Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights - GlobeNewsWire
- 6 weeks ago - BioAtla Announces Formal Process to Evaluate Strategic Options to Monetize Assets - GlobeNewsWire
- 3 months ago - BioAtla and GATC Health Announce a $40 Million Special Purpose Vehicle (SPV) Transaction to Advance Ozuriftamab Vedotin (Oz-V) into a Registrational Trial for 2L+ Oropharyngeal Squamous Cell Carcinoma (OPSCC) - GlobeNewsWire
- 5 months ago - BioAtla Enters into Agreements for up to $22.5 Million Flexible Financing - GlobeNewsWire
- 5 months ago - BioAtla Reports Third Quarter 2025 Financial Results and Highlights Recent Progress - GlobeNewsWire
- 5 months ago - BioAtla's Mecbotamab Vedotin (Mec-V), an AXL-targeting ADC, Demonstrates a Median Overall Survival (OS) of 21.5 months in Subtypes of Refractory Soft Tissue Sarcomas - GlobeNewsWire
- 5 months ago - BioAtla to Announce Third Quarter 2025 Financial Results and Provide Business Highlights on November 13, 2025 - GlobeNewsWire